Spending for Advanced Cancer Diagnoses: Comparing Recurrent Versus De Novo Stage IV Disease

PURPOSE: Spending for patients with advanced cancer is substantial. Past efforts to characterize this spending usually have not included patients with recurrence (who may differ from those with de novo stage IV disease) or described which services drive spending. METHODS: Using SEER-Medicare data fr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Oncol Pract
Autors principals: Hassett, Michael J., Banegas, Matthew, Uno, Hajime, Weng, Shicheng, Cronin, Angel M., O’Keeffe Rosetti, Maureen, Carroll, Nikki M., Hornbrook, Mark C., Ritzwoller, Debra P.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2019
Matèries:
ORIGINAL CONTRIBUTIONS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6804885/
https://ncbi.nlm.nih.gov/pubmed/31107629
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.19.00004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars